The presence of BRAF mutation in most individuals with HCL and the response of these patients have suggested that BRAF mutations are an oncogenic driver in this disease,17 but in this study BRAF V600E mutation appeared not to have very important role in HCL pathogenesis. This evidence concerns the gene BRAF and hairy cell leukemia.